Sildenafil Powder, For Suspension
Product Images NDC 60219-2651

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 60219-2651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Sildenafil Powder For Oral Suspension 1)

A chart showing fold change and 90% confidence interval for area under curve (AUC) and maximum concentration (Cmax) of Sildenafil when coadministered with various interacting drugs. The graph compares changes relative to Sildenafil alone and provides dosing recommendations such as 'No dose adjustment' or 'Coadministration not recommended' for drugs including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir.*

FDA Label Image

E (Sildenafil Powder For Oral Suspension 10)

An instructional illustration showing a hand holding an inverted bottle and measuring liquid suspension in a syringe. The image demonstrates drawing liquid medication with volume markings of 0.5 mL and 2 mL on the syringe. It is likely part of dosing instructions for oral suspension.*

FDA Label Image

F (Sildenafil Powder For Oral Suspension 11)

An instructional illustration showing a hand holding a bottle, with another hand pulling a syringe upward from the bottle. This depicts the process of withdrawing suspension from the bottle with the syringe, likely related to Sildenafil powder for suspension 10 mg/mL by Amneal Pharmaceuticals.*

FDA Label Image

G (Sildenafil Powder For Oral Suspension 12)

A black and white instructional illustration showing an adult administering an oral suspension medication by placing a syringe into the mouth, near the lips. An arrow indicates the direction of medication delivery into the mouth. The figure is labeled 'Adult'.*

FDA Label Image

H (Sildenafil Powder For Oral Suspension 13)

An instructional illustration labeled Figure H showing how to hold and rotate a bottle with a screw cap, likely demonstrating mixing or preparing a liquid medication suspension.*

FDA Label Image

I (Sildenafil Powder For Oral Suspension 14)

An instructional illustration showing a faucet with water flowing into a syringe. The syringe is marked with volume measurements, set at 7 mL and 15 mL, indicating it is being filled with water from the tap. This diagram likely depicts a step for preparing a liquid medication suspension.*

FDA Label Image

1 (Sildenafil Powder For Oral Suspension 15)

Label for Sildenafil Oral Suspension, 10 mg/mL, powder for suspension by Amneal Pharmaceuticals NY LLC. The label indicates grape flavor, 112 mL after reconstitution, with storage instructions and dosage information. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, and distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

FDA Label Image

2 (Sildenafil Powder For Oral Suspension 16)

Label for Sildenafil for Oral Suspension 10 mg/mL powder, for oral use, manufactured by Amneal Pharmaceuticals NY LLC. The label includes directions for reconstitution by adding a total of 90 mL water to the powder in the bottle to obtain 112 mL suspension. It is grape flavored and marked Rx only. Storage and discard instructions, manufacturer and distributor information are included.*

FDA Label Image

2 (Sildenafil Powder For Oral Suspension 2)

A forest plot chart showing the fold change and 90% confidence intervals in pharmacokinetic parameters (AUC, Cmax, INR AUC, INR Cmax, and bleeding time) for various drugs interacting with sildenafil. The chart compares these values relative to the interacting drug alone, with recommendations on dose adjustments, indicating 'No dose adjustment' or 'Coadministration not recommended' for certain drugs. The x-axis represents the fold change on a logarithmic scale from 0.5 to 2.*

FDA Label Image

3 (Sildenafil Powder For Oral Suspension 3)

A line chart depicting change from baseline (meters) on the vertical axis against week of study on the horizontal axis, at weeks 4, 8, and 12. The chart compares four groups: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID, with data points and error bars for each time point. A legend below identifies each group's marker style.*

FDA Label Image

4 (Sildenafil Powder For Oral Suspension 4)

A forest plot showing placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various patient subgroups, including baseline walk distance, etiology, PH criteria for functional capacity, gender, age, mean PAP, and PVRI. Each subgroup is presented with sample sizes and confidence intervals visualized with diamond markers and horizontal bars.*

FDA Label Image

5 (Sildenafil Powder For Oral Suspension 5)

A Kaplan-Meier survival curve graph showing the percent of subjects without a clinically worsening event over time in days from randomization. Two groups are compared: one receiving placebo and the other receiving Sildenafil. The y-axis represents the percent without event, and the x-axis shows days up to 112, illustrating differences in event-free survival between the two groups over time.*

FDA Label Image

A (Sildenafil Powder For Oral Suspension 6)

An illustration showing components of Sildenafil oral suspension packaging and dosing device. It depicts a cap, bottle adaptor, and a bottle labeled as sildenafil oral suspension with a discard after date. Additionally, it shows an oral dosing syringe labeled with tip, barrel, and plunger parts.*

FDA Label Image

B (Sildenafil Powder For Oral Suspension 7)

An instructional illustration showing a hand holding a bottle with arrows indicating shaking the bottle up and down, alongside a stopwatch image indicating timing. The figure is labeled as Figure B.*

FDA Label Image

C (Sildenafil Powder For Oral Suspension 8)

An instructional diagram labeled Figure C showing a hand gripping and twisting the cap of a bottle, demonstrating how to open or close it. The bottle is filled with liquid and has an arrow indicating the direction to turn the cap.*

FDA Label Image

D (Sildenafil Powder For Oral Suspension 9)

An instructional diagram showing two steps for using an oral suspension syringe with a medication bottle. The first step illustrates pressing the syringe plunger, and the second shows inserting the syringe into the bottle to draw liquid medication. The bottle contains a measurement scale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.